Showing results (151-160 of 278) with videos related to
Sort By:
Pageof 28
Pharmaceutical Patent Analyst|November 19, 2013
Discussion of PARP inhibitors in cancer therapyMonica Wielgos, Eddy S YangPharmaceutical Patent Analyst|November 19, 2013
Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009-July 2013)Guiying Li, Morten Jørgensen, Brian M CampbellPharmaceutical Patent Analyst|June 28, 2016
How might the Trans-Pacific Partnership impact on the pharmaceutical sector in Vietnam?Nguyen Hoa Binh, Pham Ngoc Kieu Anh, Nguyen Minh PhuongPharmaceutical Patent Analyst|December 21, 2013
P2X3 and P2X2/3 receptor antagonistsHedvig Bölcskei, Bence FarkasPharmaceutical Patent Analyst|December 21, 2013
Small-molecule arginase inhibitorsYan A Ivanenkov, Nina V ChufarovaPharmaceutical Patent Analyst|April 19, 2016
Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?Susan K Finston, Neil S Davey, Elina Davé, et al.Pharmaceutical Patent Analyst|April 19, 2016
Patent highlights: December 2015-January 2016Hermann Am MuckePharmaceutical Patent Analyst|February 19, 2016
The trials and tribulations of repurposing metformin and other generic drugs for tuberculosisBruce E BloomPharmaceutical Patent Analyst|February 4, 2017
Novel linkers and connections for antibody-drug conjugates to treat cancer and infectious diseaseThomas H PillowPageof 28